巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Adaptimmune Therapeutics plc

    ADAP
    1.510
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Adaptimmune Therapeutics plc - 延遲價格・最後更新於 23/05 22:00
    最高位
    --
    最低位
    --
    開市價
    --
    前收市價
    1.510
    成交量(千)
    --
    成交額(百萬)
    --
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    244.42
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    6.860 - 1.260
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Adaptimmune Therapeutics plc
    證券代碼
    ADAP.US
    所屬板塊
    Biotechnology
    公司業務
    Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.
    發行量
    156732303
    公司總部
    60 Jubilee Avenue, Milton Park
    公司網址
    https://www.adaptimmune.com
    公司電郵
    IR@adaptimmune.com
    公司電話
    +44 1235430000
    暫無內容

    關於

    Adaptimmune Therapeutics plc(ADAP.US)所屬的行業板塊為Biotechnology。
    Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.
    詳細公司背景可參考: https://www.adaptimmune.com